Radial Width of the Temporal Horn: A Sensitive Measure in Alzheimer Disease

References

1. ↵
   Radebaugh TS, Khachaturian S, eds. Report of the Working Group on Biological Markers of Alzheimer’s Disease. Chicago: Ronald and Nancy Reagan Research Institute–Alzheimer’s Association; 1997
2. ↵
   Juottonen K, Laakso MP, Partanen K, Soininen H. Comparative MRI analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer’s disease. AJNR Am J Neuroradiol 1999;20:139–144

   Abstract/FREE Full Text
3. ↵
   Jack CR, Petersen RC, Cheng Xu Y, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 1997;49:786–794

   Abstract/FREE Full Text
4. ↵
   Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer’s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19:23–31

   CrossRefPubMedWeb of Science
5. ↵
   DeCarli C, Kaye JA, Horwitz B, Rapoport SI. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 1990;40:872–883

   FREE Full Text
6. ↵
   Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179–1183

   CrossRefPubMedWeb of Science
7. ↵
   Jobst KA, Smith AD, Szatmari M, et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer’s disease. Lancet 1994;343:829–830

   CrossRefPubMedWeb of Science
8. ↵
   George AE, de Leon MJ, Stylopoulos LA, et al. CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol 1990;11:101–107

   Abstract/FREE Full Text
9. ↵
   de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14:897–906

   Abstract/FREE Full Text
10. ↵
    Soininen H, Puranen M, Riekkinen PJ. Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry 1982;45:50–54

    Abstract/FREE Full Text
11. ↵
    Scheltens PH, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–972

    Abstract/FREE Full Text
12. ↵
    Frisoni GB, Beltramello A, Weiss C, Geroldi C, Bianchetti A, Trabucchi M. Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol 1996;17:913–923

    Abstract
13. ↵
    Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer’s disease. Arch Neurol 1993;50:305–310

    CrossRefPubMedWeb of Science
14. ↵
    DeCarli C, Murphy DG, McIntosh AR, Teichberg D, Schapiro MB, Horowitz B. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995;57:119–130

    CrossRefPubMedWeb of Science
15. ↵
    Jack CR Jr, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology 1998;51:993–999

    Abstract/FREE Full Text
16. ↵
    Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M. Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver’s personal characteristics. J Am Geriatr Soc 1999;47:196–202

    PubMedWeb of Science
17. ↵
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198

    CrossRefPubMedWeb of Science
18. ↵
    Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M. Mini-mental state examination: a normative study in an Italian elderly population. Eur J Neurol 1996;3:198–202

    CrossRefPubMed
19. ↵
    McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group. Neurology 1984;34:939–944

    Abstract/FREE Full Text
20. ↵
    Dooneief G, Marder K, Tang MX, Stern Y. The Clinical Dementia Rating scale: community-based validation of “profound” and “terminal” stages. Neurology 1996;46:1746–1749

    Abstract/FREE Full Text
21. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467–1472

    Abstract/FREE Full Text
22. ↵
    Frisoni GB, Beltramello A, Binetti G, et al. Computed tomography in the detection of the vascular component in dementia. Gerontology 1995;41:121–128

    PubMedWeb of Science
23. ↵
    van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080–1083

    Abstract/FREE Full Text
24. ↵
    Binetti G, Magni E, Padovani A, Cappa SF, Bianchetti A, Trabucchi M. Neuropsychological heterogeneity in mild Alzheimer’s disease. Dementia 1993;4:321–326
25. ↵
    Metitieri T, Geroldi C, Pezzini A, Frisoni GB, Bianchetti A, Trabucchi M. The ITEL-MMSE: an Italian telephone version of the MMSE. Int J Geriatr Psychiatry 2001;16:167–168
26. ↵
    Ferrucci L, Del Lungo I, Guralnik JM, et al. Is the telephone interview for cognitive status a valid alternative in persons who cannot be evaluated by the Mini Mental State Examination? Aging 1998;10:332–338

    PubMed
27. ↵
    Frisoni GB, Govoni S, Trabucchi M, Franceschini G. Apolipoprotein E e4 allele and risk of dementia. JAMA 1995;273:375–376

    CrossRefPubMedWeb of Science
28. ↵
    Dahlbeck SW, McCluney KW, Yeakley JW, Fenstermacher MJ, Bonmati C, Van Horn G. The interuncal distance: a new RM measurement for the hippocampal atrophy in Alzheimer’s disease. AJNR Am J Neuroradiol 1991;12:931–932

    FREE Full Text
29. ↵
    Barr AN, Heinze WJ, Dobben GD, Valvassori GE, Sugar O. Bicaudate index in computed tomography of Huntington’s disease and cerebral atrophy. Neurology 1978;28:1196–1200

    Abstract/FREE Full Text
30. ↵
    Laakso M, Frisoni GB, Kononen M, et al. Hippocampus and entorhinal cortex in frontotemporal dementia. A qualitative MRI study. Biol Psychiatry 2000;47:1056–1063

    CrossRefPubMedWeb of Science
31. ↵
    Duvernoy HM, ed. The Human Hippocampus. Functional Anatomy, Vascularization and Serial Sections with MRI 2nd ed. Berlin: Springer; 1998
32. ↵
    Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM. Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol 1995;16:637–643

    Abstract
33. ↵
    Frisoni GB, Laakso MP, Beltramello A, et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease. Neurology 1999;52:91–100

    Abstract/FREE Full Text
34. ↵
    Frisoni GB, Beltramello A, Geroldi C, Weiss C, Bianchetti A, Trabucchi M. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry 1996;61:157–165

    Abstract/FREE Full Text
35. ↵
    Geroldi C, Pihlajamaki M, Laakso MP, et al. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999;53:1825–1832

    Abstract/FREE Full Text
36. ↵
    Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer’s disease. Ann Neurol 1995;37:596–604

    CrossRefPubMedWeb of Science
37. ↵
    DeCarli C, Maisog J, Murphy DG, Teichberg D, Rapoport SI, Horwitz B. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr 1992;16:274–284

    CrossRefPubMedWeb of Science
38. ↵
    DeCarli C, Murphy DGM, Gillette JA, et al. Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol 1994;15:689–696

    Abstract/FREE Full Text
39. ↵
    Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678–681

    FREE Full Text
40. ↵
    Insausti R, Juottonen K, Soininen H, et al. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neuroradiol 1998;19:659–671

    Abstract
41. ↵
    Hastie T, Tibshirani R, eds. Generalized Additive Models. London: Chapman & Hall; 1990
42. ↵
    Ebel RL. Estimation of the reliability of ratings. Psychometrika 1951;16:407–424

    CrossRefWeb of Science
43. ↵
    Spector PE, ed. Summated Rating Scale Construction: an Introduction (Quantitative Applications in the Social Sciences). London: Sage Publications; 1992
44. ↵
    Frisoni GB, Beltramello A, Bianchetti A, Trabucchi M. Hippocampal atrophy as detected by width of the temporal horn is greater in Alzheimer’s dementia than non-dementing cognitive impairment. AJNR Am J Neuroradiol 1997;18:1192–1193

    PubMed
45. ↵
    Braak H, Braak E. Morphological criteria for the recognition of Alzheimer’s disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 1994;15:355–356

    CrossRefPubMedWeb of Science
46. ↵
    Bigler ED, Blatter DD, Anderson CV, et al. Hippocampal volume in normal aging and traumatic brain injury. AJNR Am J Neuroradiol 1997;18:11–23

    Abstract
47. ↵
    Rosler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial. BMJ 1999;318:633–640

    Abstract/FREE Full Text
48. ↵
    Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT, for the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology 1998;50:136–145

    Abstract/FREE Full Text
49. ↵
    Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, and the Donepezil MSAD Study Group. Benefits of donepezil on global function, behavior, cognition, and ADLs in patients with moderate-to-severe Alzheimer’s disease (abstr). Neurology 2000;54(Suppl 3):A469
50. ↵
    Cummings J, Anand R, Koumaras B, Hartman R. Rivastigmine provides behavioral benefits to Alzheimer’s disease patients residing in a nursing home: findings from a 26-week trial (abstr). Neurology 2000;54(Suppl 3):A468
51. ↵
    Sano M, Ernesto C, Thomas RG et al., for the members of the Alzheimer’s Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 1997;336:1216–1222

    CrossRefPubMedWeb of Science
52. ↵
    Chui H, Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology’s practice parameters. Neurology 1997;49:925–935

    Abstract/FREE Full Text
53. ↵
    Wahlund LO, Julin P, Johansson SE, Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia. A comparative study. J Neurol Neurosurg Psychiatry 2000;69:630–635

    Abstract/FREE Full Text